Objective: Comparative effectiveness research has mostly been focused on comparison of treatment techniques. The goal of the present study was to extend the research to physician specialty. Background: Both surgeons and interventionalists (cardiologists and radiologists) are involved in endovascular repairs (EVAR) of aortic aneurysms, with different residency education, operative experience, preoperative assessment and patient selection, and postoperative continuity of care. Methods: Retrospective analysis was performed using the Nationwide Inpatient Sample from 1998 to 2009. Patients undergoing EVAR for abdominal aortic aneurysm were identified with International Classification of Diseases, Ninth Revision, procedure code 39.71. Using physician identifiers available in the database, surgeons were identified by case experience in the same calendar year with elective open AAA repairs, arteriovenous fistula repairs, or carotid endarderectomy. Multivariate analysis adjusted for physician volume, AAA ruptured status, patient demographic and comorbidities, and hospital characteristics. Results: A total of 28,094 EVARs were analyzed. Unadjusted mortality rates, length of stay, and total hospital charges were significantly higher for patients treated by interventionalists than those by surgeons (all Ps < 0.001). This difference persisted on multivariate analysis, where interventionalists were associated with increased likelihood of mortality (odds ratio = 1.39; 95% confidence interval, 1.04-1.89), longer length of stay (1.32 days; 95% confidence interval, 1.03-1.62), and higher total hospital charges ($19,312; 95% confidence interval, 16,471-22,153). Conclusions: Physician specialty is associated with patient outcomes. Surgeons are associated with improved outcomes, with lower mortality, shorter length of stay, and lower charges for EVAR cases, when compared with interventionalists. This finding has significant implications for future comparative effectiveness research and potential policy changes in patient referrals or physician admitting privileges.
parison of different therapeutic techniques, such as different drugs or devices, or techniques, such as laparoscopic versus traditional open approach. The impact of physician specialty on patient outcomes, with differences in clinical training and/or experiences, has been less studied.
Within surgery, previous work has identified relationships between surgeon volume [3] [4] [5] and surgeon fellowship training on postoperative outcomes. [6] [7] [8] However, there has been less work in identifying differences in operations that exist at the intersection of surgical and nonsurgical providers, with mixed findings. In a study of carotid artery stenting outcomes, the outcomes of surgeons and nonsurgeons were found to be equivalent. 9 In contrast, in studies of peripheral arterial diseases, there were opposite conclusions regarding the outcomes of surgeons versus interventionalists. 10, 11 In the case of endovascular repair (EVAR) for abdominal aortic aneurysm (AAA), patients may receive treatment from either a surgeon or an interventionalist (ie, interventional radiologist or interventional cardiologist). Given the relative higher risks of these procedures, and in view of the recent rapid adoption of EVAR, 12 it is important to understand whether physicians with very different residency training backgrounds have a comparative effectiveness in performing this procedure. Therefore, the purpose of this study was to investigate the hypothesis that no differences exist between surgeons and interventionalists in patient outcomes for EVAR.
METHODS

Inclusion and Exclusion Criteria
Retrospective analysis was completed using the Nationwide Inpatient Sample (NIS). The NIS is the largest national administrative database for all payer categories and represents a 20% stratified sample of US hospitals. Patients undergoing EVAR for AAA from 2001 to 2009 were identified using the International Classification of Diseases, Ninth Revision (ICD-9), procedure code 39.71 for "endovascular implantation of graft for abdominal aorta; endovascular repair of abdominal aortic aneurysm with graft."
Patients were excluded from analysis in instances of conversion from EVAR to open AAA repair. These were identified by the presence of both an EVAR procedure code and an ICD-9 code indicating an open repair (38.44). With this criterion, 151 patient admissions were excluded. 1 of 6 age categories: younger than 50, 50 to 59, 60 to 69, 70 to 79, 80 to 89, and older than 89 years. Charlson Comorbidity Index was calculated to assess patient comorbidities, using the method established by Romano and colleagues. 13 As a surrogate for severity, patients were labeled as having a ruptured AAA on the basis of whether or not they had an ICD-9 diagnosis code 44.13 for "abdominal aneurysm, rupture." The presence of hypovolemic shock was also used as an additional measure of severity using the ICD-9 diagnosis code 785.59.
Surgeon Identification
Surgeons and interventionalists were identified within the NIS by using unique "attending physician" and "surgeon" anonymous identifiers as done in previous studies using the NIS. 3, 5, 6, 14 Because the provider identifiers are unique to the database, provider operations can be tracked across multiple hospitals for those employed at more than 1 institution. 5 Given potential concerns that the provider variable changed from year to year, and issues with accuracy across years, 5 each provider identifier was considered a unique entity per year even when presented across multiple years. Therefore, the unit used is a provideryear, and a provider with the same identification in 2000 and 2001 was considered a separate entity for each year.
Providers performing EVAR for AAA were considered to be surgeons if we demonstrated that they had completed at least 1 elective case of open AAA repair (ICD-9 code 38.44) within the year corresponding to their provider-year. To account for the possibility that younger surgeons might not have had the opportunity to complete an open repair of AAA, providers were also labeled as surgeons if they had completed an elective arteriovenous fistula repair (ICD-9 code 39.53) or carotid endarderectomy (ICD-9 code 38.12) within the same year. Providers for the cohort of patients undergoing EVAR for AAA were considered "interventionalists" if they did not meet the aforementioned criteria.
Provider identifiers were also used to determine the total number of AAA EVAR cases that a physician had performed in a given year. Providers were then classified as low volume if they had completed 10 or fewer EVAR operations and as high volume if they had completed more than 10 annually. Provider volume status was subsequently used as a covariate in multivariate analysis.
Statistical Analysis
Statistical analysis was performed using commercially available software (STATA/SE 11.2; Stata Corp LP, College Station, TX). Multivariate analyses were performed using multivariate logistic regression models, adjusting for whether the AAA was ruptured, provider EVAR volume, patient insurance status, race, hospital teaching status, Charlson Comorbidity Index, age, geography, and year. Statistical significance was established at the 5% significance level.
RESULTS
Patient Characteristics
A total of 28,094 patients were identified as having undergone EVAR for AAA from 2001 to 2009 (Table 1 ). The average (median) age of the population was 73.4 (74) years. Perhaps, because most patients were of eligible age for Medicare, the great majority carried either Medicare or private insurance (97.9%). Most were white (90.7%), male (81.9%), and from an urban setting (94.5%). The majority of patients presented without mention of rupture (97.1%) and with fewer than 3 comorbidities (78%).
Provider Characteristics
A total of 4060 surgeon-years and 1165 interventionalist-years were identified from 2001 to 2009 (Table 1) . Surgeons had a significantly greater mean annual EVAR volume than interventionalists (6.4 vs 1.9 procedures; P < 0.001).
There were a number of significant differences in patient demographics between the 2 provider cohorts. The distribution of insurance status and race varied between surgeons and interventionalists. Patients of surgeons tended to be older than those of interventionalists. Patients of surgeons also tended to have a slightly higher mean Charlson Comorbidity Index than those of interventionalists. Incidence of ruptured AAA among interventionalists was significantly higher than that for surgeons.
Unadjusted mortality rates, mean total hospital charges, and mean LOS for elective EVAR were also significantly different between patients of surgeons and interventionalists. The unadjusted mortality rate among patients of surgeons was 2.0%, whereas that of interventionalists was 4.3% (P < 0.001). Patients of surgeons were associated with mean total hospital charges of $76,300 versus $105,400 for interventionalists (P < 0.001). Patients of surgeons had an average LOS of 3.69 days, whereas those of interventionalists were admitted for an average of 5.88 days (P < 0.001).
Analysis of AAA EVAR over time reveals at least 2 trends ( Figs. 1A, B ). First, the total number of AAA EVAR operations has increased over time. Between 2001 and 2009, the total number of procedures more than doubled from approximately 2000 to 4000. Observed increases in volume seem to be driven primarily by increases in surgeon volume, although interventionalist volume increased during this period as well. Second, differences in risk-adjusted mortality rates between interventionalists and surgeons persist over time. 
Independent Effect of Provider Specialty on Mortality, Hospital Charges, and LOS
On multivariate analysis (Table 2) , after controlling for provider annual EVAR volume, AAA rupture status, presence of hypovolemic shock, hospital teaching status, patient comorbidities, and patient demographic variables, provider specialty was associated with significant variation in mortality, total hospital charges, and LOS. Interventionalists were associated with more than a 39% increased likelihood of in-hospital mortality (odds ratio = 1.39; case volumes of fewer than 5. At volumes of 5 or more, differences between the 2 provider groups lost statistical significance. Other significant findings were noted on the multivariate analysis. Asians and Pacific Islanders had an increased risk of mortality relative to whites. Women were more likely to die than men. Interestingly, variation in the risk of mortality was not observed with differences in age. And, over time, the adjusted risk of death in 2009 was approximately half of that in 2001, perhaps indicative of increasing experience with a relatively new technique.
Upon analyzing risk-adjusted mortality rates between surgeons and interventionalists in subset populations of nonruptured cases, ruptured cases, Medicare/privately insured patients, females, those older than 65 years, and those with a Charlson Comorbidity Index of 3 or more, interventionalists exhibit consistently higher adjusted rates of mortality ( Fig. 3) . Similarly, risk-adjusted LOS is significantly higher among patients of interventionalists than those of surgeons. Although not displayed, risk-adjusted total hospital charges demonstrated similar results.
DISCUSSION
We demonstrate by multivariate analysis that interventionalists are associated with a significant increased likelihood of mortality in patients undergoing EVAR for AAA. This result occurs even when controlling for patient demographics, hospital teaching status, AAA rupture status, and provider EVAR volume. The observed difference in outcomes between interventionalists and surgeons persists over time, but it is relatively less in more recent years. Differences in patient mortality were statistically insignificant for providers with annual volume of at least 5 AAA EVAR operations. Similarly, we demonstrate by multivariate analysis that interventionalists are associated with higher total hospital charges and LOS.
These results suggest that surgeons have a comparative advantage in the quality and efficiency of completing EVAR for AAA. There are a number of mechanisms that may explain these results. It is possible that different referral patterns may allow surgeons more autonomy in patient selection. For example, the surgeon consults in a preoperative setting and selects suitable candidates. In comparison, interventionalists (which, in this study, are composed mostly of interventional radiologists) may have limited preoperative assessment, being called to do a procedure by request on already hospitalized patients. However, hospitals that have interventionalists should also have surgeons available, and one would expect the admitting team to call for a surgical consultant for sicker patients. As such, the constraints of preoperative intervention are unlikely to account for the observed differences where interventionalists have worse outcomes.
A more reasonable explanation for these results is that the education of a surgeon yields superior results relative to interventionalists. Surgeons manage patients perioperatively and receive training to quickly recognize complications that arise during this period. Patients treated by interventional radiologists, in comparison, are most likely managed postoperatively by the referring internist who may lack adequate training in perioperative management and complications. Given that surgeon selection in this study was based on exposure to open AAA repairs, a more comprehensive background conveying experience in open operations may also endow surgeons with skills that result in improved patient outcomes. Specifically, surgical training and subsequent experience with open AAA repair might provide surgeons performing EVAR with skills in patient assessment necessary to avert potential complications or adverse events.
Although a surgeon's training may improve outcomes, this study provides additional evidence that differences in outcomes associated with training can be mitigated by increasing provider volume. High-volume providers, regardless of specialty, were associated with a reduction in the likelihood of mortality, decreased LOS, and decreased total charges. Moreover, deficits associated with provider specialty were rectified by increases in volume. This was demonstrated by the loss of statistical significance in patient mortality between providers performing at least 5 cases per year. The diminishing difference in patient mortality between providers as annual volume increases suggests that policies requiring minimal annual caseloads might improve equivalency across providers of various backgrounds.
Time also seems to minimize variation between providers of different backgrounds. Although it is unclear what mechanism is driving the association between time and outcomes, improvements in technique, dissemination of information, and improvements in the usability of devices might decrease the relevancy of differences in provider background or volume on patient outcomes.
Our study has several strengths and limitations. Use of a nationally representative database such as the NIS is a major strength of our study design. The primary benefit of the NIS is that it captures patients across all ages and geographic locations. A secondary benefit of the NIS is that it provides provider identifiers with which physician behavior can be analyzed.
Our study is limited in that it may not be generalizable to patients outside of EVAR for AAA. Although the comparative advantage in EVAR currently seems to lie with the surgeons, future work will be needed to determine whether similar differences exist for different procedures within other fields of surgery. For example, interventionalists may achieve better outcomes in procedures that were once under the exclusive jurisdiction of neurosurgeons. Moreover, analysis is limited to patients in an inpatient setting and does not reflect operations that occur in the outpatient setting.
This study is also limited in that operations involving a team approach using both a surgeon and an interventionalist could not be identified. As such, this study cannot comment on the impact that collaborative procedures may have on patient outcomes. Understanding whether a team approach improves patient outcomes will be an important consideration for future work, given that involving an additional provider increases resource utilization. 
Physician Specialty and EVAR Outcomes
This study is limited by the absence of clinical imaging results within the NIS. Therefore, there may be concerns regarding patient selection biases between interventionalists and surgeons if interventionalists select patients with difficult anatomy for EVAR rather than referring for open repair. However, there are several reasons that this is unlikely to be true. Surrogates for patient severity including hypovolemic shock and rupture status were included in multivariate analysis. Therefore, the observed results were independent of, and above and beyond, such differences between surgeons and interventionalists. Analysis was also conducted in the subset of patients with unruptured aneurysms to exclude the possibility that baseline differences in patient severity were confounding the association between provider specialty and patient outcomes.
Our study has important policy implications. Health policies in support of selective referrals for AAA repairs, or granting hospital admitting privileges to the interventionalists, may be discussed. Furthermore, this study provides impetus to question if and how procedures ought to be regulated when they occur at the intersection of different training backgrounds. One might hypothesize that gains in both economic efficiencies and patient outcomes might be had if similar studies could identify which specialty has the comparative advantage for a given procedure and then encourage greater division of labor between the specialties. Another option is to require minimal annual volumes at a critical threshold identified by CER. Future CER should be expanded to examine the impact of physician specialty training in cases where there is a significant overlap between specialties.
CONCLUSIONS
With the continuing evolution of medicine and increased interventionalist involvement in a number of procedures that previously fell under the domain of surgeons, this study identifies potential advantages of the surgery status quo: decreased patient mortality, LOS, and total hospital charges. It also identifies that these advantages are possible for interventionalists with higher volumes. It further reminds the medical community of the need for continuous monitoring and evaluation as new procedures and techniques are adopted.
DISCUSSANTS K.C. Kent (Madison, WI):
When I first became a vascular surgeon 25 years ago, it was difficult to get recruitment to this specialty. There were few who wanted to care for a group of patients for whom procedures were long and tedious, reoperations were common, and outcomes were not always favorable. Fast forward to 2013 where everybody wants to be a vascular surgeon, cardiologists, interventional radiologists, nephrologists, dermatologists, vascular medicine physicians, and many others.
Why the dramatic change? For the nonsurgeons, the reason is the development of minimally invasive technology that has allowed any specialist with catheter-based skills to participate in vascular care.
So, is it appropriate for nonsurgical specialists to treat patients with vascular disease? This question has been addressed by Dr Talamini and colleagues with regard to endovascular aneurysm repair, and their answer is a resounding no. They found increased mortality, increased LOS, and increased costs when patients with aneurysms were treated by nonsurgical specialists.
Having spent 11 years as a vascular division chief, and the past few years as the department chair, this is a controversy with which I have a great deal of familiarity. I began with the view many years ago that only vascular surgeons should treat vascular disease. However, over time, I have come to realize that patients, payers, and perhaps the world at large have little interest in the name of our specialty, whether it is that we are a cardiologist or a surgeon or a radiologist. That is really irrelevant to our constituents.
What does make a difference is outcome. Thus, a cardiologist who has extensive knowledge of vascular disease, a high-volume practice, and, mind you, who achieves excellent outcomes could claim a role in the treatment of patients with vascular disease. So, how can we explain the findings of Dr Talamini and colleagues?
It may be that nonsurgeon interventionalists in general do not have sufficient background or training in vascular disease to make the correct judgments about treatment of such patients. Or, alternatively, these interventionalists, because their primary focus is in other areas, may have insufficient procedural volume to become technically adept at endovascular aneurysm repair. This leads to a few questions.
You have used the term "vascular surgeon" in your presentation and in the article. However, many of these procedures may have been performed by general surgeons or cardiac surgeons. Were you able to differentiate between surgeon types? Are the outcomes different for vascular versus other surgeons? Should a low-volume general surgeon be excluded from treating these patients?
Many of these procedures were performed by teams of individuals, a cardiologist and a cardiac surgeon, or a general surgeon and a radiologist. Were you able to identify these patients? Is the team approach a viable option as long as a surgeon is involved?
The critical question, however, is whether the suboptimal outcomes for the interventionalists are related to volume, or is the issue training and background? Is the answer both, and if that is so, what is the relative importance of each?
This question has practical implications. If the issue is volume, then interventionalists should be allowed to participate in the care of patients with vascular disease if they focus their practice on vascular disease and maintain adequate volume. However, if the issue is training and experience, then interventionalists should not be allowed to participate until or unless their training paradigms are changed.
The moral of the story is that expertise in disease is far more important than expertise in technology.
Response From S. Wilson (Orange, CA):
I am very pleased with that. A happy man is said not to make a reliable critic, but in this case, I think you have.
We did not differentiate between vascular surgeons and general surgeons, although we are aware that others, for example, Dimick at the University of Michigan, have shown better outcomes when a vascular surgeon specialty is at work. We focused on surgeons versus nonsurgeons, reasoning that it is probably unusual for a general surgeon to perform an EVAR procedure today. The procedures are so technically complex, it is not possible to do just a few of these and remain expert at it.
We did not use any other analysis except the multivariate logistic regression analysis that we used here, but it is certainly possible that our risk stratification may be imperfect. For example, it may not be able to pick up differences in complex aortic anatomy, very large common iliac arteries, not a good landing zone, perirenal aneurysm. So this may be an issue that is at work.
You commented on teams, and what we did was identify the team leader as the specialty person. We could control for volume but not for training, experience, and expertise. These issues, I think, are very important.
I think, though, the key is patient selection, and if you think about it, the vascular surgeon in his office has the ability to make an elective decision, carefully considered, and decide whether or not he is going to actually perform the procedure. The hospital-based radiologist may not have that opportunity. He receives a call, a procedure on an inpatient is requested, and he feels obligated to proceed. Another aspect may be postoperative care, where patients undergoing vascular surgery will receive their postoperative care under the direction of the surgeon.
DISCUSSANTS K.L. Mattox (Houston, TX):
I extend my questions to your methods and the issue of a gunshot wound to the aorta, which is similar to a ruptured AAA, or a leaking AAA, or even a ruptured one taken care of either in the military zone or by an acute care surgeon. Therefore, my questions are similar to Dr. Kent's in the drilling down on what is a vascular surgeon.
You excluded in your presentation the emergency procedure for a leaking abdominal aneurysm, but those are becoming germane, especially to the acute care surgeon and to the emergency surgeon, or even the trauma surgeon.
Trauma surgeons and acute care surgeons are now acquiring catheter-based and wire-based skills, not only for the civilian sector but also for the military sector and especially for noncompressible hemorrhage control. It is my suggestion and/or question that your hypothesis now must be extended to card-carrying vascular surgeons versus the acute care surgeon, and is there a difference in their results, especially during an emergency procedure?
Response From S. Wilson (Orange, CA):
Of course that would be another study we would need to do, and I will comment, though, that our definition of a vascular surgeon was an individual who had performed an open aneurysm, a vascular access case, or a carotid endarterectomy in that year. Now, we started off by defining it as a vascular surgeon who had done an open case that year and then we began to rapidly realize that that is quite possible, open cases are very unusual for aortic aneurysm surgery.
And, of course, we did eliminate ruptured aneurysms. You can see that there is some bias in selection, because, in the total analysis, there were more ruptured aneurysms (2% or 3%) that were referred to the inhospital interventionalists, but those were eliminated from the study.
Clearly, there have been advances in management of vascular trauma by endovascular means, and I would just give you the example of the subclavian artery injury underneath the clavicle, which is so difficult to get at, which can be managed so nicely with an endovascular prosthesis, with a graft placed. So, yes, I think that is important, and perhaps another day we will have the results of that versus open surgery.
DISCUSSANTS
R.S. Rhodes (Philadelphia, PA):
I have one comment about surgeon type. Data at the American Board of Surgery suggest that general surgeons who still perform vascular surgery actually do so in a substantial volume. So, such surgeons may also have acquired endovascular skills.
My question relates to differences in aneurysm characteristics among different types of specialists, and I wonder whether you analyzed aneurysm size. In the case of small aneurysms, judgment may have affected the decision to proceed. For small aneurysms, did you see a difference among specialty types?
Response From S. Wilson (Orange, CA):
Excellent point. Of course, the larger aneurysm has distorted anatomy, a shorter neck, wider iliac arteries, and represent a much more difficult case. We did not analyze the data by aneurysm size, but I suspect that would be relatively easy to do, and that would make a nice contribution maybe at a vascular meeting.
DISCUSSANTS J.J. Ricotta (Washington, DC):
One brief question. Did you compare the individuals who were treated by surgeons versus the individuals who were treated by radiologists in terms of age and comorbidity?
